Seeking Alpha

Elan ELN, which has a 25% ownership stake in Pfizer (PFE) and Johnson & Johnson's failed...

Elan ELN, which has a 25% ownership stake in Pfizer (PFE) and Johnson & Johnson's failed bapineuzumab project, is also trading down after hours, along with Eli Lilly (LLY), who has a similar Alzheimer's candidate, solanezumab, for which clinical results are expected in coming weeks. ELN -8.7%, LLY -2.1%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs